UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE TO. (Rule 13e-4)

Size: px
Start display at page:

Download "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE TO. (Rule 13e-4)"

Transcription

1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE TO (Rule 13e-4) TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 Fitbit, Inc. (Name of Subject Company (Issuer) and Name of Filing Person (Offeror)) Options to Purchase Class A Common Stock, par value $ per share Options to Purchase Class B Common Stock, par value $ per share (Title of Class of Securities) 33812L102 (CUSIP Number of Class A Common Stock Underlying Class of Securities) Andy Missan, Esq. Executive Vice President and General Counsel Fitbit, Inc. 405 Howard Street San Francisco, California (415) (Name, Address, and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of Filing Person) Copies to: Cynthia C. Hess, Esq. Jeffrey R. Vetter, Esq. Fenwick & West LLP 801 California Street Mountain View, California (650)

2 CALCULATION OF FILING FEE Transaction Valuation* Amount of Filing Fee* NotApplicable* NotApplicable* *Afilingfeeisnotrequiredinconnectionwiththisfilingasitrelatessolelytopreliminarycommunicationsmadebeforethecommencementofatenderoffer. CheckboxifanypartofthefeeisoffsetasprovidedbyRule0-11(a)(2)andidentifythefilingwithwhichtheoffsettingfeewas previouslypaid.identifythepreviousfilingbyregistrationstatementnumber,ortheformorscheduleandthedateofitsfiling. Amount Previously Paid: Notapplicable. Filing Party: Notapplicable. Form or Registration No.: Notapplicable. Date Filed: Notapplicable. x Checktheboxifthefilingrelatessolelytopreliminarycommunicationsmadebeforethecommencementofatenderoffer. Checktheappropriateboxesbelowtodesignateanytransactionstowhichthestatementrelates: third-partytenderoffersubjecttorule14d-1. xissuertenderoffersubjecttorule13e-4. going-privatetransactionsubjecttorule13e-3. amendmenttoschedule13dunderrule13d-2. Checkthefollowingboxifthefilingisafinalamendmentreportingtheresultsofthetenderoffer: Attachedare(i)theDefinitiveProxyStatementforthe2017AnnualMeetingofStockholdersofFitbit,Inc.( Fitbit orthe Company )tobeheldonmay25, 2017 (the Definitive Proxy Statement ), which contains a proposal submitted to the Company s stockholders to approve a proposed stock option exchange program( Program ),that,ifimplemented,wouldalloweligibleemployees,includingfitbit sexecutiveofficersotherthanitspresident,chiefexecutiveofficer, andchairman,chieftechnologyofficer,andchieffinancialofficer,toexchangeout-of-the-moneyor underwater optionstopurchasesharesoffitbit sclass AcommonstockorClassBcommonstockcurrentlyheldbysucheligibleemployeesforalessernumberofnewrestrictedstockunitsthatmaybesettledfor sharesoffitbit sclassacommonstockunderfitbit s2015equityincentiveplan;(ii)awrittencommunicationsentbythepresident,chiefexecutiveofficer, andchairmanoffitbittofitbitemployeesonapril13,2017regardingtheprogram;(iii)abullet-pointlistofbasicinformationabouttheprogram,whichwas attached to the written communication referred to in (ii) above; and (iv) a Proposed Stock Option Exchange Program Q&A made available to the Fitbit s employeesonapril13,2017.

3 The Program has not yet commenced. Fitbit will file a Tender Offer Statement on Schedule TO with the Securities and Exchange Commission ("SEC") upon the commencement of the Program. Eligible employees of Fitbit should read the Tender Offer Statement on Schedule TO and other related materials when those materials become available, because they will contain important information about the Program. In connection with the proposal to be voted on by Fitbit s stockholders with respect to the Program, Fitbit has filed a definitive proxy statement with the SEC. Fitbit stockholders are urged to read the definitive proxy statement before making any voting decision regarding the Program because it will contain important information about the proposal to be voted on by stockholders with respect to the Program. Fitbit stockholders and option holders will be able to obtain the written materials described above and other documents filed by Fitbit with the SEC free of charge from the SEC s website at In addition, stockholders and option holders may obtain free copies of the documents filed by Fitbit with the SEC by directing a written request to: Fitbit, Inc., 405 Howard Street, Suite 550, San Francisco, California 94105, Attention: Investor Relations.

4 Item 12. Exhibits Exhibit Number Description DefinitiveProxyStatementforthe2017AnnualMeetingofStockholders(filedwiththeSEConApril13,2017and incorporatedhereinbyreference) communicationsenttoemployeesofFitbit,Inc.onApril13, BasicInformationregardingtheproposedOptionExchangeProgram,datedApril13, ProposedStockOptionExchangeProgramQ&A,datedApril13,2017.

5 Exhibit from James Park Proposed Stock Option Exchange Program HiEveryone, Wehavebeenactivelyexploringwaystoaddressemployeestockoptiongrantsthatare underwater, meaningtheexercisepriceiscurrentlyhigherthanourshare price.werecognizestockoptiongrantsareimportantincentivesandwewanttoensureyouhavetheopportunitytorealizethesebenefitsinthewaytheywere intended. Wehavesubmittedastockholderproposaltoapproveavoluntarystockoptionexchangeprogramthatwouldalloweligibleemployeestoexchange,atatwofor oneratio, underwaterstockoptionsforrestrictedstockunits. Forexample, ifyoutender10,000sharessubjecttoaneligibleoption, youwillbegranted5,000 RSUs. Stockholderswillvoteontheexchangeprogramatourannualstockholders meetingonmay25 th,2017.untilstockholdersvoteontheprogramandadateisset tobegintheexchange,thereisnoactionneededbyyou.onceadateissettobegintheexchange,eligibleemployeeswillreceivedetailedinformationsoyouwill haveeverythingyouneedtomakeadecisionthat srightforyou.aftertheexchangebegins,youwillhave20businessdaystodecidewhethertoparticipate.inthe meantime,youcanreviewtheattachedinformationandfrequentlyaskedquestionsabouttheprogram.i llupdateyouagainfollowingourannualstockholders meetingonmay25th. Thankyouforallyourhardworkandeffort.Wehopetocontinuetoworktoensurethatyourvaluablecontributionstothecompanyarerecognizedandrewarded. James The option exchange described in this letter has not yet commenced. Fitbit, Inc., or Fitbit, will file a Tender Offer Statement on Schedule TO with the Securities and Exchange Commission, or SEC, upon the commencement of the option exchange. Eligible employees of Fitbit should read the Tender Offer Statement on Schedule TO and other related materials when those materials become available, because they will contain important information about the option exchange. In connection with the proposal to be voted on by Fitbit s stockholders with respect the option exchange discussed in this letter, Fitbit has filed a definitive proxy statement with the SEC. Fitbit stockholders are urged to read the definitive proxy statement before making any voting decision regarding the option exchange, because they will contain important information about the proposal to be voted on by stockholders referenced in this letter. Fitbit stockholders and option holders will be able to obtain the written materials described above and other documents filed by Fitbit with the SEC free of charge from the SEC s website at In addition, stockholders and option holders may obtain free copies of the documents filed by Fitbit with the SEC by directing a written request to: Fitbit, Inc., 405 Howard Street, Suite 550, San Francisco, California 94105, Attention: Investor Relations.

6 Exhibit 99.3 Proposed Stock Option Exchange Program Basic Information BasicInformation OptionexchangeprogramsaregovernedbySecuritiesandExchangeCommissionandNewYorkStockExchangeregulations.Detailsoftheproposedexchange programareoutlinedinourdefinitiveproxystatement,whichcanbefoundat[link]. Withstockholderapproval,weanticipatethattheexchangeprogramwillcommenceinJune2017. Onceadateissettobegintheexchange,eligibleemployeeswillreceivedetailedinformation.Sodon tworry-youwillbeprovidedwitheverythingyouneedto knowtomakeadecisionthat srightforyou.oncetheexchangebegins,youwillhave20businessdaystodecidewhethertoparticipate. Whichoptionsareeligibleforexchange?Onlythosestockoptionsthatareoutstandingandunexercisedasofimmediatelypriortoourcommencementofthe tenderoffer(the ExchangeOffer )andthatare underwater becausetheyhaveanexercisepricethatisgreaterthanthefairmarketvalueoftheclassa commonstockandclassbcommonstockontheexchangedate,whichiscurrentlyexpectedtobethefirstbusinessdateaftertheexpirationoftheexchange Offer. Isanyoneexcludedfromparticipating?OurPresident,ChiefExecutiveOfficer,andChairman,ChiefTechnologyOfficer,andChiefFinancialOfficer(James Park,EricFriedmanandBillZerella)-aswellasourboardmembers,arenotallowedtoparticipateintheexchangeprogram.Formeremployeeswhostillhold optionsalsoareexcluded. Eligibleemployeesparticipatinginthestockoptionexchangeprogramwillreceiveonenewrestrictedstockunit,orRSU,foreverytwosharessubjecttoa surrenderedstockoption. VestingoftheRSUswillbedeterminedbasedonthevestingofthestockoptionsexchanged.ThenewRSUswillgenerallyvestovertheremainingvesting periodofthesurrenderedstockoption(subjecttoaone-yearminimumvestingperiod),subjecttotheeligibleemployee scontinuedservicewithusoverthe remainingvestingperiod. OutsideoftheUnitedStates,anoptionexchangemaybesubjecttolocalregulationsthatwillresultindifferencesinhowtheexchangeisexecuted.Whenever possible,wewillfollowthesameapproachinallcountries.eligibleemployeesoutsidetheunitedstateswillreceiveinformationabouttheirlocalplanatthe appropriatetime. Ifyouhavequestions,please []. Key legal disclosure The option exchange described in this summary has not yet commenced. Fitbit, Inc., or Fitbit, will file a Tender Offer Statement on Schedule TO with the Securities and Exchange Commission, or SEC, upon the commencement of the option exchange. Eligible Employees of Fitbit should read the Tender Offer Statement on Schedule TO and other related materials when those materials become available, because they will contain important information about the option exchange. In connection with the proposal to be voted on by Fitbit s stockholders with respect to the option exchange discussed in this summary, Fitbit has filed a definitive proxy statement with the SEC. Fitbit stockholders are urged to read the definitive proxy statement before making any voting decision regarding the option exchange, because they will contain important information about the proposal to be voted on by stockholders referenced in this summary. 1

7 Fitbit stockholders and option holders will be able to obtain the written materials described above and other documents filed by Fitbit with the SEC free of charge from the SEC s website at In addition, stockholders and option holders may obtain free copies of the documents filed by Fitbit with the SEC by directing a written request to: Fitbit, Inc., 405 Howard Street, Suite 550, California 94105, Attention: Investor Relations. 2

8 Exhibit 99.4 Fitbit, Inc. Frequently Asked Questions About Proposed Stock Option Exchange Program What is the Proposed Stock Option Exchange Program? SinceourinitialpublicofferinginJune2015,ourstockpricehasfluctuatedsignificantly.Asaresult,someofouremployeeshold underwater stockoptions, withexercisepricesthatarehigherthanthecurrenttradingpriceofourclassacommonstock.theproposedstockoptionexchangeprogram(the Program )is designedtoalloweligibleemployeestoexchangesuchunderwateroptionsforalessernumberofrsus. How many RSUs will I receive if I exchange my eligible options? EligibleemployeesparticipatingintheProgramwillreceiveonenewRSUforeverytwosharessubjecttoasurrenderedeligibleoption.Forexample,ifyoutender 10,000sharessubjecttoaneligibleoption,youwillbegranted5,000RSUs. If I participate in the Program, what is the vesting on the new RSUs? VestingoftheRSUswillbedeterminedbasedonthevestingofthestockoptionsexchanged.ThenewRSUswillgenerallyvestovertheremainingvestingperiod ofthesurrenderedstockoption(subjecttoaone-yearminimumvestingperiod),subjecttotheeligibleemployee scontinuedservicewithusovertheremaining vestingperiod.forexample,ifyouroriginaloptiongranthada4yearvestingscheduleandyouhavevestedfortwoyears,thenewrsuwillhaveatwoyear vestingschedule. Why are we exchanging options for RSUs? ExchangingoptionsforRSUsisconsistentwithourcurrentcompensationapproachandwebelievethisexchangeprovidesthebestpotentialequitycompensation valueforemployeeswithunderwateroptions. Why has the company decided on these particular terms for the exchange? WebelievethatgivingouremployeestheopportunitytoexchangeunderwaterstockoptionsforalessernumberofRSUsisanimportantstepinretainingand motivatingemployees.thisprogramrecognizesthatunderwaterstockoptiongrantshavenotdeliveredthevaluetoemployeeswehopedatthetimetheywere granted.theoptionexchangewillgiveouremployeestheopportunitytodecidewhetheritmakessensetotradecertainoptionsandrealignportionsoftheirequity compensationwithcurrentmarketconditions. What is the expected timeline of the Program? WearecurrentlyseekingstockholderapprovalfortheProgram.WehavenotcommencedtheProgram,andwewillnotdosounlessourstockholdersapprovethis proposalatourannualstockholders meetingonmay25,2017. IfourstockholdersapprovetheProgram, wecurrentlyanticipatecommencingtheprograminjune2017.oncetheprogrambegins, eligibleemployeeswillbe givenatleast20u.s.businessdaystodecidewhethertoexchangeallorsomeoftheireligibleoptionsforrsus.the ExchangeDate iscurrentlyexpectedtobe thefirstbusinessdateaftertheexpirationofthe20u.s.businessdayperiod. NotethatthetimelinemaychangeasourboardofdirectorsandcompensationcommitteewillultimatelydeterminethefinaltermsandconditionsoftheProgram. Additionaldetailswillbeprovidedatalaterdate. 1

9 Who is eligible to participate in the Program? WeexpectthattheProgramgenerallywillbeopentoallU.S.employees,exceptourPresident,ChiefExecutiveOfficer,andChairman,ChiefTechnologyOfficer, andchieffinancialofficer(jamespark,ericfriedmanandbillzerella),andtoemployeeswhoarelocatedoutsideoftheunitedstates,wherepermittedbylocal law. Which options are eligible to exchange under the Program? Onlystockoptionsthatare(i)outstandingandunexercisedasofimmediatelypriortothecommencementoftheProgramand(ii)haveanexercisepricethatis greaterthanthefairmarketvalueofourclassacommonstockandclassbcommonstockontheexchangedatewillbeeligiblefortheprogram. IfyouhavetenderedstockoptionspursuanttotheProgramwhich,duetofluctuationsinthestockprice,arenotunderwaterontheExchangeDate,thesestock optionswillnotbeexchangedfornewrsusandyouwillcontinuetoholdthosestockoptions. Ifthestockoptionsyouholdare notunderwater immediately priortothecommencement oftheprogram, butmay beunderwater ontheexchangedate, you shouldconsiderwhetheryouwouldliketotendersuchstockoptionstopreserveyourabilitytoparticipateintheexchangeshouldthefairmarketvalueoftheclass AcommonstockandClassBcommonstockfallbelowtheexercisepriceofyourstockoptionsontheExchangeDate. Forexample,assume: wecommencedtheprogramonjune1,2017; thepriceofourclassacommonstockwas$5.00pershareonjune1,2017;and duringthe20businessdaysfollowingjune1,2017,thepriceofourclassacommonstockfellsuchthatitwas$4.25pershareontheexchangedate (assumedheretobejune30,2017). IfyouheldanoutstandingandunexercisedstockoptionforClassAcommonstockonJune1,2017thathadanexercisepriceof$4.52,youmayelecttotender yourstockoptionforexchangebeforetheendofthe20businessdayperiod,evenifyourstockoptionisnotunderwateronthedatethatyoutenderyourstock option. Inthisexample,yourtenderedstockoptionwouldbeexchangedontheExchangeDatebecausethefairmarketvalueontheexchangedate($4.25)islowerthan theexercisepriceofyourstockoption($4.52).conversely,ifthefairmarketvalueontheexchangedatewashigherthantheexercisepriceofyourpreviously tenderedstockoption,yourstockoptionwouldnotbeexchangedandyouwouldcontinuetoholdthatstockoption. Do I have to participate in the Program? No.ParticipationintheProgramwillbecompletelyvoluntary.IfyoudonotparticipateintheProgram,youreligibleoptionswillcontinuewiththesameexercise priceandotherwiseremainsubjecttotheirexistingterms. What should I do? Right now, there s nothing you need to do. The next step is stockholder approval of the proposed exchange at our annual stockholders meeting on May 25. Assumingstockholdersapprovetheoptionexchangeprogram, weanticipatecommencingtheprograminjune2017. Onceadateissettobegintheexchange, eligibleemployeeswillreceivedetailedinformation, providingyouwitheverythingyouneedtoknowtomakeadecisionthat sbestforyou. Ifyouhaveany questions,please []. 2

10 The option exchange described in this summary has not yet commenced. Fitbit, Inc., or Fitbit, will file a Tender Offer Statement on Schedule TO with the Securities and Exchange Commission, or SEC, upon the commencement of the option exchange. Eligible employees of Fitbit should read the Tender Offer Statement on Schedule TO and other related materials when those materials become available, because they will contain important information about the option exchange. In connection with the proposal to be voted on by Fitbit s stockholders with respect to the amendment of certain Fitbit equity incentive plans to permit the option exchange discussed in this summary, Fitbit has filed a definitive proxy statement with the SEC. Fitbit stockholders are urged to read the definitive proxy statement before making any voting decision regarding the option exchange, because they will contain important information about the proposal to be voted on by stockholders referenced in this summary. Fitbit stockholders and option holders will be able to obtain the written materials described above and other documents filed by Fitbit with the SEC free of charge from the SEC s website at In addition, stockholders and option holders may obtain free copies of the documents filed by Fitbit with the SEC by directing a written request to: Fitbit, Inc., 405 Howard Street, Suite 550, San Francisco, California 94105, Attention: Investor Relations. 3

EBAY INC FORM SC TO-C. (Written communication relating to an issuer or third party) Filed 03/10/09

EBAY INC FORM SC TO-C. (Written communication relating to an issuer or third party) Filed 03/10/09 EBAY INC FORM SC TO-C (Written communication relating to an issuer or third party) Filed 03/10/09 Address 2145 HAMILTON AVENUE SAN JOSE, CA 95125 Telephone 408-376-7400 CIK 0001065088 Symbol EBAY SIC Code

More information

KLA TENCOR CORP. FORM SC TO-I (Tender offer statement by Issuer) Filed 2/27/2007. SAN JOSE, California Telephone CIK

KLA TENCOR CORP. FORM SC TO-I (Tender offer statement by Issuer) Filed 2/27/2007. SAN JOSE, California Telephone CIK KLA TENCOR CORP FORM SC TO-I (Tender offer statement by Issuer) Filed 2/27/2007 Address 160 RIO ROBLES SAN JOSE, California 95134 Telephone 408-434-4200 CIK 0000319201 Industry Semiconductors Sector Technology

More information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE TO (Amendment No. 1) AbbVie Inc. (Name of Subject Company (Issuer))

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE TO (Amendment No. 1) AbbVie Inc. (Name of Subject Company (Issuer)) QuickLinks -- Click here to rapidly navigate through this document As filed with the Securities and Exchange Commission on May 1, 2018 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE

More information

SIGMATRON INTERNATIONAL, INC. SIGMATRON INTERNATIONAL, INC.

SIGMATRON INTERNATIONAL, INC. SIGMATRON INTERNATIONAL, INC. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 SIGMATRON INTERNATIONAL, INC. (Name

More information

DELL TECHNOLOGIES INC. (Name of Subject Company (Issuer) and Filing Person (Offeror))

DELL TECHNOLOGIES INC. (Name of Subject Company (Issuer) and Filing Person (Offeror)) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 13e-4) Tender Offer Statement Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 1) DELL

More information

Fitbit, Inc. (Name of Issuer)

Fitbit, Inc. (Name of Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. ) Fitbit, Inc. (Name of Issuer) Class A Common Stock, $0.0001

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* INVITAE CORPORATION (Name of Issuer) COMMON STOCK, $0. 0001

More information

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13E-3 (Rule 13e-100)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13E-3 (Rule 13e-100) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13E-3 (Rule 13e-100) TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 13e-3 THEREUNDER (Amendment

More information

OMRIX BIOPHARMACEUTICALS, INC. Filed by JOHNSON & JOHNSON

OMRIX BIOPHARMACEUTICALS, INC. Filed by JOHNSON & JOHNSON OMRIX BIOPHARMACEUTICALS, INC. Filed by JOHNSON & JOHNSON FORM SC TO-T/A (Amended tender offer statement by Third Party) Filed 12/12/08 Address 630 FIFTH AVENUE, 22ND FLOOR NEW YORK, NY 10111 Telephone

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C SCHEDULE TO. PHARMACYCLICS, INC. (Names of Subject Company)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C SCHEDULE TO. PHARMACYCLICS, INC. (Names of Subject Company) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO AMENDMENT NO. 3 (RULE 14D-100) Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange

More information

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13E-3 (Rule 13e-100)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13E-3 (Rule 13e-100) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13E-3 (Rule 13e-100) TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 13e-3 THEREUNDER (Amendment

More information

Page 2 of 199 UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C FORM 10-K

Page 2 of 199 UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C FORM 10-K Page 2 of 199 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal

More information

Ocata Therapeutics, Inc. (Name of Subject Company (Issuer)) Laurel Acquisition Inc. an indirect wholly-owned subsidiary of

Ocata Therapeutics, Inc. (Name of Subject Company (Issuer)) Laurel Acquisition Inc. an indirect wholly-owned subsidiary of SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 5) Ocata

More information

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Schedule TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 Amendment No. 2 GLOBAL

More information

SCHEDULE 13D (Rule 13d-101)

SCHEDULE 13D (Rule 13d-101) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 240.13d-1(a) AND AMENDMENTS THERETO FILED

More information

CC MEDIA HOLDINGS, INC.

CC MEDIA HOLDINGS, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 13e-4) TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR SECTION 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934

More information

American Axle & Manufacturing Holdings, Inc. (Name of Issuer)

American Axle & Manufacturing Holdings, Inc. (Name of Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 0 SCHEDULE D Under the Securities Exchange Act of (Amendment No. ) American Axle & Manufacturing Holdings, Inc. (Name of Issuer) Common

More information

As filed with the Securities and Exchange Commission on December 15, SECURITIES AND EXCHANGE COMMISSION Washington, D.C.

As filed with the Securities and Exchange Commission on December 15, SECURITIES AND EXCHANGE COMMISSION Washington, D.C. Section 1: SC TO-I (SC TO-I) As filed with the Securities and Exchange Commission on December 15, 2016 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under

More information

Chicago Bridge & Iron Company N.V. (Name of Subject Company (Issuer))

Chicago Bridge & Iron Company N.V. (Name of Subject Company (Issuer)) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 Chicago Bridge & Iron

More information

ACACIA RESEARCH CORPORATION (Exact name of registrant as specified in its charter)

ACACIA RESEARCH CORPORATION (Exact name of registrant as specified in its charter) 8-K 1 a8k-director_contestx2018.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 240.13d-1(a) AND AMENDMENTS THERETO FILED

More information

ZYNGA INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS

ZYNGA INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS ZYNGA INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS FORM SC 13G/A (Amended Statement of Ownership) Filed 11/08/12 Address 699 EIGHTH STREET SAN FRANCISCO, CA 94103 Telephone 800-762-2530 CIK 0001439404

More information

LEAR CORP FORM SC TO-I. (Tender offer statement by Issuer) Filed 08/14/08

LEAR CORP FORM SC TO-I. (Tender offer statement by Issuer) Filed 08/14/08 LEAR CORP FORM SC TO-I (Tender offer statement by Issuer) Filed 08/14/08 Address 21557 TELEGRAPH ROAD SOUTHFIELD, MI 48033 Telephone 2484471500 CIK 0000842162 Symbol LEA SIC Code 2531 - Public Building

More information

THERAVANCE INC. FORM SC TO-T/A (Amended tender offer statement by Third Party) Filed 9/13/2007

THERAVANCE INC. FORM SC TO-T/A (Amended tender offer statement by Third Party) Filed 9/13/2007 THERAVANCE INC FORM SC TO-T/A (Amended tender offer statement by Third Party) Filed 9/13/2007 Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO, California 94080 Telephone 650-808-6000 CIK 0001080014 Industry

More information

NORCRAFT COMPANIES, INC. Filed by FORTUNE BRANDS HOME & SECURITY, INC.

NORCRAFT COMPANIES, INC. Filed by FORTUNE BRANDS HOME & SECURITY, INC. NORCRAFT COMPANIES, INC. Filed by FORTUNE BRANDS HOME & SECURITY, INC. FORM SC TO-T/A (Amended tender offer statement by Third Party) Filed 05/12/15 Address 3020 DENMARK AVENUE SUITE 100 EAGAN, MN 55121

More information

THE WALT DISNEY COMPANY

THE WALT DISNEY COMPANY UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event

More information

Brookfield Residential Properties Inc.

Brookfield Residential Properties Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13E-3 (Amendment No. 1) TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 13e-3

More information

Twilio, Inc. (Name of Issuer)

Twilio, Inc. (Name of Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Twilio, Inc. (Name of Issuer) CLASS A COMMON STOCK, $0.001

More information

DELL TECHNOLOGIES INC. (Name of Subject Company (issuer) and Filing Person (offeror))

DELL TECHNOLOGIES INC. (Name of Subject Company (issuer) and Filing Person (offeror)) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 13e-4) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 DELL TECHNOLOGIES INC.

More information

Washington, D.C SCHEDULE 13D/A Under the Securities Exchange Act of 1934

Washington, D.C SCHEDULE 13D/A Under the Securities Exchange Act of 1934 p2992149-13da2.htm http://www.sec.gov/archives/edgar/data/155953/9141211478... 2/4/214 4:54 PM SC 13D/A 1 p2992149-13da2.htm SCHEDULE 13D/A (AMENDMENT NO. 2) SECURITIES AND EXCHANGE COMMISSION Washington,

More information

Raptor Pharmaceutical Corp. (Name of Subject Company) Misneach Corporation

Raptor Pharmaceutical Corp. (Name of Subject Company) Misneach Corporation UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 Raptor Pharmaceutical

More information

SECURITIES AND EXCHANGE COMMISSION FORM SC 14D9/A. Filing Date: SEC Accession No (HTML Version on secdatabase.

SECURITIES AND EXCHANGE COMMISSION FORM SC 14D9/A. Filing Date: SEC Accession No (HTML Version on secdatabase. SECURITIES AND EXCHANGE COMMISSION FORM SC 14D9/A Tender offer solicitation / recommendation statements filed under Rule 14d-9 [amend] Filing Date: 2000-07-07 SEC Accession No. 0000950123-00-006349 (HTML

More information

MTGE INVESTMENT CORP. MOUNTAIN MERGER SUB CORPORATION ANNALY CAPITAL MANAGEMENT, INC.

MTGE INVESTMENT CORP. MOUNTAIN MERGER SUB CORPORATION ANNALY CAPITAL MANAGEMENT, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO (RULE 14D-100) Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934

More information

Deutsche Bank AG Taunusanlage 12, D Frankfurt am Main Federal Republic of Germany. Jeffrey A. Ruiz Vice President Telephone: (212)

Deutsche Bank AG Taunusanlage 12, D Frankfurt am Main Federal Republic of Germany. Jeffrey A. Ruiz Vice President Telephone: (212) Deutsche Bank AG Taunusanlage 12, D-60325 Frankfurt am Main Federal Republic of Germany Jeffrey A. Ruiz Vice President Telephone: (212) 469-3667 February 12, 2003 Securities and Exchange Commission SEC

More information

CORRESP 1 filename1.htm

CORRESP 1 filename1.htm Page 1 of 15 CORRESP 1 filename1.htm VIA EDGAR AND HAND DELIVERY Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Re: Barbara C. Jacobs, Assistant Director Evan S. Jacobson,

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D. Alliqua BioMedical, Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D. Alliqua BioMedical, Inc. (Name of Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* Alliqua BioMedical, Inc. (Name of Issuer) Common Stock,

More information

Amendment No. 1 to SCHEDULE TO. Filing Party: Hospitality Investors Trust, Inc.

Amendment No. 1 to SCHEDULE TO. Filing Party: Hospitality Investors Trust, Inc. As filed with the Securities and Exchange Commission on May 24, 2018 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 1 to SCHEDULE TO TENDER OFFER STATEMENT UNDER

More information

SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1 )*

SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1 )* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1 )* MMR INFORMATION SYSTEMS, INC. (Name of Issuer) Common Stock, par value

More information

TASTY BAKING CO Filed by FLOWERS FOODS INC

TASTY BAKING CO Filed by FLOWERS FOODS INC TASTY BAKING CO Filed by FLOWERS FOODS INC FORM SC TO-C (Written communication relating to an issuer or third party) Filed 04/12/11 Address NAVY YARD CORPORATE CENTER THREE CRESCENT DRIVE, SUITE 200 PHILADELPHIA,

More information

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b) (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT

More information

MAMMOTH ENERGY SERVICES, INC. (Name of Issuer)

MAMMOTH ENERGY SERVICES, INC. (Name of Issuer) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) Under the Securities Exchange Act of 1934 MAMMOTH ENERGY SERVICES, INC. (Name of Issuer) Common Stock, $0.01 par value

More information

BANKERS TRUST COMPANY One Bankers Trust Plaza New York, New York Vice President P.O. Box 318. New York, NY

BANKERS TRUST COMPANY One Bankers Trust Plaza New York, New York Vice President P.O. Box 318. New York, NY BANKERS TRUST COMPANY One Bankers Trust Plaza New York, New York 10006 Don R. De Souza Mailing Address: Vice President P.O. Box 318 Telephone: 212-250-2216 Church Street Station New York, NY 10008 February

More information

ShotSpotter, Inc. (Name of Issuer)

ShotSpotter, Inc. (Name of Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ShotSpotter, Inc. (Name of Issuer) Common Stock, $0.005

More information

SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Nemus Bioscience, Inc. (Name of Issuer)

SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Nemus Bioscience, Inc. (Name of Issuer) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Nemus Bioscience, Inc. (Name of Issuer) Common Stock, $.001 par value

More information

Capital Markets REPRESENTATIVE TRANSACTIONS

Capital Markets REPRESENTATIVE TRANSACTIONS Capital Markets REPRESENTATIVE TRANSACTIONS Helping businesses grow. Avidbank Holdings Private Placement $20 million Central Pacific Financial Corp. Secondary Offering $175 million July 2017 June 2015

More information

CHARMING SHOPPES, INC. (Name of Subject Company (Issuer)) COLOMBIA ACQUISITION CORP. (Offeror) A Wholly Owned Subsidiary of

CHARMING SHOPPES, INC. (Name of Subject Company (Issuer)) COLOMBIA ACQUISITION CORP. (Offeror) A Wholly Owned Subsidiary of UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 CHARMING SHOPPES, INC.

More information

NICE-SYSTEMS LTD. (Name of Subject Company (Issuer) and Filing Person (Offeror))

NICE-SYSTEMS LTD. (Name of Subject Company (Issuer) and Filing Person (Offeror)) Filename: zk96935.htm Type: SC TO-I/A Comment/Description: (this header is not part of the document) SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO SCHEDULE TO TENDER OFFER

More information

PHARMACYCLICS, INC. (Exact name of registrant as specified in its charter)

PHARMACYCLICS, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

VIKING THERAPEUTICS, INC. (Name of Issuer)

VIKING THERAPEUTICS, INC. (Name of Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* VIKING THERAPEUTICS, INC. (Name of Issuer) Common Stock,

More information

Dealing With Underwater Options

Dealing With Underwater Options Dealing With Underwater Options Option Repricings, Option Exchanges, Option Buyouts Benjamin I. Delancy S. James DiBernardo Amy Pocino Kelly Zaitun Poonja February 2009 THREE TECHNIQUES FOR DEALING WITH

More information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to SCHEDULE TO Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 KBS REAL

More information

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D/A (Amendment No. 4)* Under the Securities Exchange Act of 1934

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D/A (Amendment No. 4)* Under the Securities Exchange Act of 1934 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 2549 SCHEDULE 13D/A (Amendment No. 4)* Under the Securities Exchange Act of 1934 CDK Global, Inc. (Name of Issuer) Common Stock, par value $.1 per share

More information

GENCO SHIPPING & TRADING LTD Filed by AURELIUS CAPITAL MANAGEMENT, LP

GENCO SHIPPING & TRADING LTD Filed by AURELIUS CAPITAL MANAGEMENT, LP GENCO SHIPPING & TRADING LTD Filed by AURELIUS CAPITAL MANAGEMENT, LP FORM SC 13D (Statement of Beneficial Ownership) Filed 5/5/14 Address 299 PARK AVENUE, 12TH FLOOR NEW YORK, NY, 1171 Telephone 646-443-855

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event

More information

InfraREIT, Inc. (Name of Issuer)

InfraREIT, Inc. (Name of Issuer) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 8) InfraREIT, Inc. (Name of Issuer) Common Stock, $0.01 par value (Title

More information

SURGE COMPONENTS, INC. (Name of Subject Company (Issuer) and Filing Person (Offeror))

SURGE COMPONENTS, INC. (Name of Subject Company (Issuer) and Filing Person (Offeror)) sctoi0317a1_surgecomp.htm Form Type: SC TO-I/A Page 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO SCHEDULE TO Tender Offer Statement under Section 14(d)(1)

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 2549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* ONCOSEC MEDICAL INCORPORATED (Name of Issuer) Common Stock,

More information

FORM 8-K YAHOO INC - YHOO. Filed: February 19, 2008 (period: February 12, 2008) Report of unscheduled material events or corporate changes.

FORM 8-K YAHOO INC - YHOO. Filed: February 19, 2008 (period: February 12, 2008) Report of unscheduled material events or corporate changes. FORM 8-K YAHOO INC - YHOO Filed: February 19, 2008 (period: February 12, 2008) Report of unscheduled material events or corporate changes. 8-K - FORM 8-K Table of Contents Item 5.02 Departure of Directors

More information

Deutsche Bank AG Taunusanlage 12, D Frankfurt am Main Federal Republic of Germany. Jeffrey A. Ruiz Vice President Telephone: (212)

Deutsche Bank AG Taunusanlage 12, D Frankfurt am Main Federal Republic of Germany. Jeffrey A. Ruiz Vice President Telephone: (212) Deutsche Bank AG Taunusanlage 12, D-60325 Frankfurt am Main Federal Republic of Germany Jeffrey A. Ruiz Vice President Telephone: (212) 250-3667 February 12, 2004 Securities and Exchange Commission SEC

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE TO sctoi0217_surgecomp.htm Form Type: SC TO-I Page 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) Of the Securities

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) VMWARE INC (Name of Issuer) COMMON STOCK (Title of Class

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM S-8

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM S-8 As filed with the Securities and Exchange Commission on September 7, 2011 Registration Nos. 033-85662, 033-90964, 333-37325, 333-40858, 333-97313 and 333-97315 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

More information

Netlist, Inc. (Name of Issuer)

Netlist, Inc. (Name of Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 9)* Netlist, Inc. (Name of Issuer) Common Stock, par value

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 240.13d-1(a) AND AMENDMENTS THERETO FILED

More information

Tower Semiconductor Ltd. (Name of Issuer)

Tower Semiconductor Ltd. (Name of Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 10) Tower Semiconductor Ltd. (Name of Issuer) Ordinary Shares,

More information

WELLS FARGO & COMPANY (Exact Name of Registrant as Specified in Its Charter)

WELLS FARGO & COMPANY (Exact Name of Registrant as Specified in Its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 As filed with the Securities and Exchange Commission on June 7, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Registration No. 333- FORM S-8 REGISTRATION STATEMENT UNDER

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102) Windstream Technologies, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102) Windstream Technologies, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b) (c), AND (d) AND AMENDMENTS THERETO

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Washington, D.C FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended

More information

BJ SERVICES CO Filed by BAKER HUGHES INC

BJ SERVICES CO Filed by BAKER HUGHES INC BJ SERVICES CO Filed by BAKER HUGHES INC FORM 425 (Filing of certain prospectuses and communications in connection with business combination transactions) Filed 01/12/10 Address 4601 WESTWAY PARK BLVD

More information

Restaurant Brands International Inc. (Name of Issuer)

Restaurant Brands International Inc. (Name of Issuer) Section 1: SC 13D/A (AMENDMENT NO. 5 TO SCHEDULE 13D) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 2549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 5)*

More information

Restaurant Brands International Inc. (Name of Issuer)

Restaurant Brands International Inc. (Name of Issuer) Section 1: SC 13D/A (AMENDMENT NO. 4 TO SCHEDULE 13D) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 2549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 4)*

More information

VistaGen Therapeutics, Inc. (Name of Issuer)

VistaGen Therapeutics, Inc. (Name of Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 2)* VistaGen Therapeutics, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities)

More information

Asset Acceptance Capital Corp.

Asset Acceptance Capital Corp. Page 1 of 91 10-K 1 d10k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 240.13d-1(a) AND AMENDMENTS THERETO FILED

More information

PACIFIC GAS AND ELECTRIC COMPANY

PACIFIC GAS AND ELECTRIC COMPANY NOT A NEW ISSUE REMARKETING SUPPLEMENT TO OFFICIAL STATEMENT DATED JUNE 22, 2004 $345,000,000 CALIFORNIA POLLUTION CONTROL FINANCING AUTHORITY POLLUTION CONTROL REFUNDING REVENUE BONDS (PACIFIC GAS AND

More information

IAC/INTERACTIVECORP FORM 8-K. (Current report filing) Filed 04/04/05 for the Period Ending 04/01/05

IAC/INTERACTIVECORP FORM 8-K. (Current report filing) Filed 04/04/05 for the Period Ending 04/01/05 IAC/INTERACTIVECORP FORM 8-K (Current report filing) Filed 04/04/05 for the Period Ending 04/01/05 Address 152 WEST 57TH ST 42ND FLOOR NEW YORK, NY 10019 Telephone 2123147300 CIK 0000891103 Symbol IACI

More information

Amended and Restated Wachovia Corporation 2003 Stock Incentive Plan

Amended and Restated Wachovia Corporation 2003 Stock Incentive Plan THIS DOCUMENT CONSTITUTES PART OF A PROSPECTUS COVERING SECURITIES THAT HAVE BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933. Amended and Restated Wachovia Corporation 2003 Stock Incentive Plan Prospectus

More information

FORM S-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

FORM S-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 As filed with the Securities and Exchange Commission on May 16, 2018 Registration No. 333- Delaware (State or other jurisdiction of incorporation or organization) SECURITIES AND EXCHANGE COMMISSION Washington,

More information

TIME INC. (Name of Subject Company) TIME INC. (Name of Person Filing Statement)

TIME INC. (Name of Subject Company) TIME INC. (Name of Person Filing Statement) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) (Amendment No. 4) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C Form S-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C Form S-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents As filed with the Securities and Exchange Commission on February 21, 2017 Registration No. 333-[ ] UNITED STATES SECURITIES

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended

More information

Sientra, Inc. (Exact name of registrant as specified in its charter)

Sientra, Inc. (Exact name of registrant as specified in its charter) As filed with the Securities and Exchange Commission on Registration No. 333-222453 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THESECURITIESACTOF1933

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D (Rule 13d-101) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 240.13d-1(a) AND AMENDMENTS THERETO FILED

More information

PREFERRED APARTMENT COMMUNITIES INC Filed by WILLIAMS OPPORTUNITY FUND LLC

PREFERRED APARTMENT COMMUNITIES INC Filed by WILLIAMS OPPORTUNITY FUND LLC PREFERRED APARTMENT COMMUNITIES INC Filed by WILLIAMS OPPORTUNITY FUND LLC FORM SC 13D/A (Amended Statement of Beneficial Ownership) Filed 04/11/12 Address 3284 NORTHSIDE PARKWAY NW SUITE 150 ATLANTA,

More information

Inventergy Global, Inc (Name of Issuer)

Inventergy Global, Inc (Name of Issuer) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Inventergy Global, Inc (Name of Issuer) Common Stock,

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. _ ) * AtlassianCorporationPlc (NameofIssuer) CommonStock (TitleofClassofSecurities)

More information

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* CAMBER ENERGY, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001

More information

BARRETT BUSINESS SERVICES, INC. (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number)

BARRETT BUSINESS SERVICES, INC. (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* BARRETT BUSINESS SERVICES, INC. (Name of Issuer) Common

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 14D-9 (RULE 14d-101) (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 14D-9 (RULE 14d-101) (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (RULE 14d-101) (Amendment No. 1) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(D)(4) OF THE SECURITIES EXCHANGE

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 14D-9 (RULE 14d-101) (Amendment No. 9)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 14D-9 (RULE 14d-101) (Amendment No. 9) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (RULE 14d-101) (Amendment No. 9) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(D)(4) OF THE SECURITIES EXCHANGE

More information

Accelerating Business

Accelerating Business Accelerating Business AGC/SD/SE/2018/70 December 21, 2018 To, Corporate Relationship Department Bombay Stock Exchange Limited P.J. Towers, Dalal Street, Fort, Mumbai - 400 001 Corporate Relationship DepartffletifnetworKs.com

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-K Page 1 of 126 10-K 1 d10k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

More information

Duke Energy Corporation

Duke Energy Corporation As filed with the Securities and Exchange Commission on July 7, 2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 5 TO FORM S-4 REGISTRATION STATEMENT UNDER THE

More information

MVC CAPITAL, INC. FORM N-2 (Securities Registration (close-end investment trust)) Filed 12/7/1999

MVC CAPITAL, INC. FORM N-2 (Securities Registration (close-end investment trust)) Filed 12/7/1999 MVC CAPITAL, INC. FORM N-2 (Securities Registration (close-end investment trust)) Filed 12/7/1999 Address RIVERVIEW AT PURCHASE 287 BOWMAN AVENUE, 3RD FLOOR PURCHASE, New York 10577 Telephone 914-701-0310

More information

Date of Report (date of earliest event reported): November 21, WELLS FARGO & COMPANY (Exact name of registrant as specified in its charter)

Date of Report (date of earliest event reported): November 21, WELLS FARGO & COMPANY (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event

More information

SAGE THERAPEUTICS, INC.

SAGE THERAPEUTICS, INC. SAGE THERAPEUTICS, INC. FORM S-1MEF (Registration of Additional Securities (up to 20%)) Filed 04/14/15 Address 215 FIRST STREET CAMBRIDGE, MA 02142 Telephone 617-299-8380 CIK 0001597553 Symbol SAGE SIC

More information